Barclays »

Evommune shares owned by Barclays

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Barclays

Quarter filed Position value Share count Share price at filing
2026-03-31 $46k 2.0k 22.99

More positions owned by Barclays

Ishares Tr Opt Put Option (EEM)
Microsoft Corporation (MSFT)
STATE STR SPDR S&ampP 500 ETF T Opt Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Opt Call Option (QQQ)
Ishares Tr Fund (IWM)
Apple (AAPL)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Ishares Tr Opt Put Option (HYG)
JPMORGAN CHASE &amp Opt Call Option (JPM)
Alphabet Inc Class C cs (GOOG)

View all positions for Barclays

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
Rtw Investments
MPM Oncology Impact Management
Nan Fung Group Holdings
SymBiosis Capital Partners
Eventide Asset Management
Henderson Group
Marshall Wace
Baker Bros. Advisors
Alyeska Investment Group
Defilade Capital Management
BlackRock

View all funds holding Evommune